P. Hiemstra (Leiden, Netherlands), C. Taggart (Belfast, United Kingdom)
Lipopolysacharide modulates glucocorticoid receptor function in nasal mucosa and polyp fibroblasts
L. Pujols, L. Fernández-Bertolín, J. Mullol, M. Fuentes-Prado, I. Alobid, J. Roca-Ferrer, C. Picado (Barcelona, Spain)
|  |
The role of NRF-2 and p38 MAPK on the function of human parenchymal fibroblasts
A. Lagan, N. Green, A. Walker, G. Jenkins, S. Johnson, A. Fisher, A. Knox (Nottingham, Newcastle upon Tyne, United Kingdom)
|  |
LSC 2013 abstract - NF-κbeta acts downstream of EGFR in regulating low dose cadmium induced primary lung cell proliferation
S. Kundu, A. Bhattacharyya (Kolkata, India)
| |
Notch signalling in human basophils
K. Cima, G. Gamerith, A. Amann, C. M. Kähler, J. Löffler-Ragg (Innsbruck, Austria)
| |
Neutrophil dysfunction in respiratory infection: Impaired killing efficiency after successive phagocytic stimuli?
J. Macfarlane, M. H. Ruchaud-Sparagano, J. Scott, D. Bulmer, A. Khan, J. Simpson (Newcastle upon Tyne, United Kingdom)
| |
Combination therapy may be beneficial for the treatment of lymphangioleiomyomatosis
L. Moir, H. Y. Ng, B. Oliver, J. Burgess, V. Krymskaya, J. Black (Sydney, Australia; Philadelphia, United States Of America)
| |
Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells
A. Bruno, S. Gerbino, M. Ferraro, L. Siena, A. Bonura, P. Colombo, S. La Grutta, M. Gjomarkaj, E. Pace (Palermo, Italy)
| |
Inflammatory cytokine levels in serum and bronchoalveolar lavage fluid and gene polymorphism in young adult patients with bronchiectasis
G. Ayhan, D. Tas, O. Okutan, I. Yilmaz, E. Demirer, O. Ayten, Z. Kartaloglu (Istanbul, Turkey)
| |
Down-regulation of the P2Y12 purinergic receptor expression on human bronchial epithelial cells by transforming growth factor-beta
S. Altraja, A. Altraja (Tartu, Estonia)
| |
Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis?
V. Vicens Zygmunt, C. Mendoza, G. Olvera, A. Cruz, Y. Romero, M. Montaño, C. Ramos, M. Molina, M. Selman, A. Pardo (L'Hospitalet de Llobregat, Spain; México, Mexico)
| |
Immunoproteasome expression in pulmonary fibrosis
I. Keller, A. Dann, I. Fernandez-Buelvaz, S. Takenaka, A. Günther, O. Eickelberg, S. Meiners (Munich, Giessen, Germany)
| |
CXCR1 is dispensable for allergy-driven airway leukocyte recruitment in vivo
M. Carevic, M. Bakele, S. Beer-Hammer, L. Mays, D. Bloes, P. Gierschik, S. Autenrieth, M. Kormann, B. Moepps, D. Hartl (Tübingen, Germany)
| |
Airway surface dehydration confers susceptibility to allergic airway inflammation in vivo
B. Fritzsching, L. Dai, C. van Bodegom, J. Schatterny, S. Hirtz, Z. Zhou, M. Mall (Heidelberg, Germany)
| |
The role of ATP and purinergic-receptor- signalling in the pathogenesis of ALI/ARDS
S. Cicko, K. Ayata, K. Baudiss, A. Zech, M. Idzko (Freiburg im Breisgau, Germany)
| |
Silica-induced inflammasome activation in vitro and in rat lungs
P. Peeters, N. Reynaert, I. Eurlings, T. Perkins, B. Mossman, R. Schins, E. Wouters, C. Albrecht (Maastricht, Netherlands; Burlington, United States Of America; Düsseldorf, Germany)
| |
High-intensity training induces airway hyperresponsive through neuron transdifferentiation of adrenal medulla chromaffin cells
R. He, J. Feng, Q. Xun, Q. Qin, C. Hu (Changsha, China)
| |
PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced pulmonary fibrosis by inhibition of multiple pro-inflammatory/fibrotic key mediators
B. Grouix, M. Tremblay, F. Sarra-Bournet, A. Felton, A. Doucet, P. Laurin, L. Gagnon (Laval, Canada)
| |
PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model
M. Leduc, B. Grouix, L. Gervais, F. Sarra-Bournet, M. Tremblay, P. Laurin, L. Gagnon (Laval, Canada)
| |